Targeting Cell Death Pathways in Malignant Mesothelioma
Grant award · Australia · Last reported Dec 2018
Source: GrantConnect
Malignant mesothelioma (MM) is an aggressive and incurable cancer with median patient survival of 12 months. By screening a panel of MM cell lines against a new class of drugs that directly target the natural cell death mechanisms in tumour cells, we identified two specific 'survival factors' in MM. Co-targeting of these molecules leads to potent MM cell killing. The proposed research will expand
- Status
- Prospective
- Sector
- Education, Hospital, Government
- Location
- Australia
- Updated
- 19 Nov 2026
- Source
- GrantConnect
ConstructChat
Ask ConstructChat about Targeting Cell Death Pathways in Malignant Mesothelioma
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | grant award |
Taiyo status | Prospective |
Taiyo last update | 2026-11-19 |
Contact
| Not available for this record. |
Description
Description | Malignant mesothelioma (MM) is an aggressive and incurable cancer with median patient survival of 12 months. By screening a panel of MM cell lines against a new class of drugs that directly target the natural cell death mechanisms in tumour cells, we identified two specific 'survival factors' in MM. Co-targeting of these molecules leads to potent MM cell killing. The proposed research will expand these studies into animal model of MM and potentially provide new treatment options for MM patients. |
Original sector | Medical Research |
Budget |
Location
Country | Australia |
Source
Source | GrantConnect |
URL |
More Details
Record type | Project |
Sector | Education, Hospital, Government |
Article published date | 2024-12-16 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
